SG11201809928VA - Modified antimicrobial peptide derived from an arginine-rich domain - Google Patents
Modified antimicrobial peptide derived from an arginine-rich domainInfo
- Publication number
- SG11201809928VA SG11201809928VA SG11201809928VA SG11201809928VA SG11201809928VA SG 11201809928V A SG11201809928V A SG 11201809928VA SG 11201809928V A SG11201809928V A SG 11201809928VA SG 11201809928V A SG11201809928V A SG 11201809928VA SG 11201809928V A SG11201809928V A SG 11201809928VA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- sinica
- academia
- sec
- amino acids
- Prior art date
Links
- 108700042778 Antimicrobial Peptides Proteins 0.000 title abstract 3
- 102000044503 Antimicrobial Peptides Human genes 0.000 title abstract 3
- 239000003910 polypeptide antibiotic agent Substances 0.000 title abstract 3
- 239000004475 Arginine Substances 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/40—Viruses, e.g. bacteriophages
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10031—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10033—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10133—Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Dentistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662342415P | 2016-05-27 | 2016-05-27 | |
| PCT/US2017/034489 WO2017205631A1 (en) | 2016-05-27 | 2017-05-25 | Modified antimicrobial peptide derived from an arginine-rich domain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201809928VA true SG11201809928VA (en) | 2018-12-28 |
Family
ID=60411947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201809928VA SG11201809928VA (en) | 2016-05-27 | 2017-05-25 | Modified antimicrobial peptide derived from an arginine-rich domain |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20190144510A1 (enExample) |
| EP (1) | EP3464329A4 (enExample) |
| JP (1) | JP7161263B6 (enExample) |
| KR (1) | KR102530478B1 (enExample) |
| CN (1) | CN109641938A (enExample) |
| AU (1) | AU2017270201A1 (enExample) |
| BR (1) | BR112018074478A2 (enExample) |
| CA (1) | CA3024873A1 (enExample) |
| IL (1) | IL263086A (enExample) |
| MX (1) | MX2018014490A (enExample) |
| SG (1) | SG11201809928VA (enExample) |
| TW (1) | TWI635095B (enExample) |
| WO (1) | WO2017205631A1 (enExample) |
| ZA (1) | ZA201807763B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202317598A (zh) * | 2021-09-01 | 2023-05-01 | 美商艾姆麥克斯治療股份有限公司 | 具有抗微生物活性的胜肽 |
| KR102544102B1 (ko) * | 2021-11-05 | 2023-06-19 | 주식회사 레메디 | 상처 치료 및 항염증 활성을 가지는 펩타이드 및 이의 용도 |
| US11713341B1 (en) | 2022-06-17 | 2023-08-01 | Vestaron Corporation | Antimicrobial NCR13 variant peptides |
| CN116947974B (zh) * | 2023-07-25 | 2025-03-11 | 武汉大学人民医院（湖北省人民医院） | 一种来源于中药美洲大蠊的多聚精氨酸修饰肽及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998009649A1 (en) * | 1996-09-03 | 1998-03-12 | The General Hospital Corporation | Inhibition of viral replication |
| US6399570B1 (en) * | 1999-02-05 | 2002-06-04 | Agennix, Inc. | Antimicrobial/endotoxin neutralizing polypeptide |
| PL201419B1 (pl) | 2002-12-04 | 2009-04-30 | Inst Biotechnologii I Antybiot | Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina |
| EP2986115A4 (en) * | 2013-02-06 | 2017-03-01 | Academia Sinica | Antimicrobial peptides derived from hepatitis b virus core protein arginine-rich domain |
-
2017
- 2017-05-25 WO PCT/US2017/034489 patent/WO2017205631A1/en not_active Ceased
- 2017-05-25 CN CN201780032261.3A patent/CN109641938A/zh active Pending
- 2017-05-25 JP JP2018561017A patent/JP7161263B6/ja active Active
- 2017-05-25 KR KR1020187035660A patent/KR102530478B1/ko active Active
- 2017-05-25 SG SG11201809928VA patent/SG11201809928VA/en unknown
- 2017-05-25 MX MX2018014490A patent/MX2018014490A/es unknown
- 2017-05-25 BR BR112018074478-6A patent/BR112018074478A2/pt not_active IP Right Cessation
- 2017-05-25 US US16/303,464 patent/US20190144510A1/en not_active Abandoned
- 2017-05-25 EP EP17803588.7A patent/EP3464329A4/en active Pending
- 2017-05-25 CA CA3024873A patent/CA3024873A1/en not_active Abandoned
- 2017-05-25 AU AU2017270201A patent/AU2017270201A1/en not_active Abandoned
- 2017-05-26 TW TW106117731A patent/TWI635095B/zh active
-
2018
- 2018-11-18 IL IL263086A patent/IL263086A/en unknown
- 2018-11-19 ZA ZA2018/07763A patent/ZA201807763B/en unknown
-
2020
- 2020-07-17 US US16/932,372 patent/US12084479B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| TW201808985A (zh) | 2018-03-16 |
| KR102530478B1 (ko) | 2023-05-10 |
| US12084479B2 (en) | 2024-09-10 |
| JP7161263B6 (ja) | 2023-03-20 |
| IL263086A (en) | 2018-12-31 |
| EP3464329A1 (en) | 2019-04-10 |
| KR20190001954A (ko) | 2019-01-07 |
| JP2019523220A (ja) | 2019-08-22 |
| TWI635095B (zh) | 2018-09-11 |
| JP7161263B2 (ja) | 2022-10-26 |
| EP3464329A4 (en) | 2020-08-26 |
| AU2017270201A1 (en) | 2018-11-29 |
| US20210101939A1 (en) | 2021-04-08 |
| BR112018074478A2 (pt) | 2019-03-19 |
| ZA201807763B (en) | 2020-10-28 |
| WO2017205631A1 (en) | 2017-11-30 |
| US20190144510A1 (en) | 2019-05-16 |
| MX2018014490A (es) | 2019-06-24 |
| CN109641938A (zh) | 2019-04-16 |
| CA3024873A1 (en) | 2017-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201811442UA (en) | Formulation of a peptide vaccine | |
| SG11201900743UA (en) | Multiple function exercise device | |
| SG11201903012RA (en) | Anti-c1s antibodies and methods of use thereof | |
| SG11201804787UA (en) | Human immunodeficiency virus neutralizing antibodies | |
| SG11201804713VA (en) | TARGETING PEPTIDES FOR DIRECTING ADENO-ASSOCIATED VIRUSES (AAVs) | |
| SG11201806868TA (en) | Compositions and methods for protecting against airborne pathogens and irritants | |
| SG11201803958WA (en) | Nucleic acids encoding repetitive amino acid sequences rich in proline and alanine residues that have low repetitive nucleotide sequences | |
| SG11201901996UA (en) | Formulations of ( r)-2-amino-3-phenylpropyl carbamate | |
| SG11201907034PA (en) | Methods of treating influenza | |
| SG11201809857TA (en) | Anti-CTLA-4 Antibodies | |
| SG11201807912SA (en) | Vaccine against rsv | |
| SG11201809928VA (en) | Modified antimicrobial peptide derived from an arginine-rich domain | |
| SG11201811338VA (en) | A novel botulinum neurotoxin and its derivatives | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201804161VA (en) | Compositions comprising bacterial strains | |
| SG11201804510PA (en) | Biparatopic polypeptides antagonizing wnt signaling in tumor cells | |
| SG11201805888SA (en) | Cyclic dinucleotides for treating conditions associated with sting activity such as cancer | |
| SG11201803900UA (en) | Process for preparing polyurea microcapsules with improved deposition | |
| SG11201901374WA (en) | Antibiotic compounds | |
| SG11201808525UA (en) | Anti-complement factor bb antibodies and uses thereof | |
| SG11201803918VA (en) | Production of steviol glycosides in recombinant hosts | |
| SG11201810420YA (en) | Antibodies to alpha-synuclein and uses thereof | |
| SG11201810396QA (en) | Pegylated carfilzomib compounds | |
| SG11201908114UA (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
| SG11201903061YA (en) | Combination treatments comprising administration of imidazopyrazinones |